Login / Signup
RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancers.
Li Ding
Bin Deng
Gang Chen
Published in:
Molecular therapy : the journal of the American Society of Gene Therapy (2024)
Keyphrases
</>
small molecule
cancer therapy
nucleic acid
childhood cancer